LitAlert ~~ GeneLit.com

    • Knowledge and attitude of hereditary breast cancer among Japanese university female students.
    • Terui-Kohbata H, Egawa M, Yura K, Yoshida M.
    • J Hum Genet. 2020 Mar 18. doi: 10.1038/s10038-020-0743-9. [Epub ahead of print]
    • Ethical Issues in Genetic Testing for Inherited Cancer Predisposition Syndromes: the Potentially Conflicting Interests of Patients and Their Relatives.
    • Kenny J, Burcher S, Kohut K, Eastman N.
    • Curr Genet Med Rep. 2020 Mar 17. doi: 10.1007/s40142-020-00186-8. [Epub ahead of print]
    • [Medical treatment options in BRCA-associated cancers].
    • Kahán Z.
    • Magy Onkol. 2020 Mar 17;64(1):13-24. Epub 2020 Feb 10.
    • Review, [Article in Hungarian]
    • Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
    • Riedlova P, Janoutova J, Hermanova B.
    • Mol Biol Rep. 2020 Mar 16. doi: 10.1007/s11033-020-05378-7. [Epub ahead of print]
    • [The pathology of hereditary ovarian tumors].
    • Pesce F, Devouassoux-Shisheboran M.
    • Ann Pathol. 2020 Mar 13. pii: S0242-6498(20)30051-1. doi: 10.1016/j.annpat.2020.02.015. [Epub ahead of print]
    • Review, [Article in French]
    • Cell-type-specific role of CHK2 in mediating DNA damage-induced G2 cell cycle arrest.
    • van Jaarsveld MTM, Deng D, Ordoñez-Rueda D, Paulsen M, Wiemer EAC, Zi Z.
    • Oncogenesis. 2020 Mar 13;9(3):35. doi: 10.1038/s41389-020-0219-y.
    • The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review.
    • Patel M, Nowsheen S, Maraboyina S, Xia F.
    • Cell Biosci. 2020 Mar 11;10:35. doi: 10.1186/s13578-020-00390-7. eCollection 2020.